Study Links Aronvit to Boosted Gut SCFA Levels

New preclinical research on Greenvit’s Aronvit ingredient suggests it may influence gut microbiota and metabolic activity, according to findings the company says could point to potential health benefits. The ex vivo study, which has not yet been published, reportedly demonstrated measurable changes in bacterial density, short-chain fatty acid production, and specific butyrate-associated microbes following a single 200 mg dose of the extract.

Study Findings

According to the results shared by Greenvit, total bacterial density increased by 15% 24 hours after administration, while short-chain fatty acids (SCFAs) rose by 10%. Notably, the presence of Dysosmobacter welbionis, a key butyrate-associated bacterium, grew by 129%. Aronvit is a standardized extract of Aronia melanocarpa, containing at least 15% anthocyanins, 25% polyphenols, and 10% proanthocyanidins. The ingredient was introduced at Vitafoods Europe 2026.

Tomasz Sadlik, global sales director at Greenvit, explained that the study evaluates how aronia’s composition and processing affect microbial metabolism and SCFA production. He emphasized that the gut microbiome actively transforms aronia’s polyphenols, linking gut and metabolic health through changes in fermentation and metabolite generation. “The future of polyphenol ingredients lies in what the microbiome can do with it, not the quantity of compounds in an extract,” Sadlik said.

The research used SIFR technology from Cryptobiotix, which simulates the gastrointestinal tract from digestion through fermentation. Microbiota from six donors was tested, revealing significant individual variability. Sadlik noted this explains heterogeneous results in prior human studies on aronia’s effects. Greenvit’s study found Aronvit modulates microbiota related to polyphenol metabolism, supporting microbial density and consistently stimulating butyrate-associated bacteria.

“One of the most interesting findings was the consistent stimulation of butyrate-associated bacteria,” Sadlik said. “Together with the increase in SCFA production, this suggests that aronia polyphenols may support microbial cross-feeding networks that favor butyrate-producing pathways.” He reported coordinated increases in bacteria like Faecalibacterium prausnitzii, Anaerobacter hallii, Roseburia, Faecalibacillus, Gemmiger, and Coprococcus.

The study also highlighted that aronia extracts are not biologically interchangeable despite similar anthocyanin levels. Variations in total polyphenol and fiber content led to distinct microbiome and metabolic responses. Across all extracts, researchers observed changes in SCFA production, luminal pH, and microbial metabolite generation from polyphenols. “This functional perspective may be more informative than looking at bacterial diversity alone,” Sadlik noted.

Greenvit’s standardization process involves selecting raw materials tested in an in-house lab for anthocyanin and polyphenol levels. The company uses membrane technology with water as a solvent to create the extract, aiming for a product “as close to nature as possible.” Sadlik stressed that standardization reflects product stability, knowledge, and quality. He added that Greenvit plans further 2027 studies with more donors to deepen understanding of aronia’s gut health impacts, collaborating with Polish medical universities.

Microbial Metabolism and Functional Activity

Sadlik explained that SCFAs provide a mechanistic bridge between gut and metabolic physiology. The research noted significant increases in acetate and propionate, while butyrate response varied by donor.

These metabolites influence intestinal barrier function and host metabolic signaling, though the ex vivo model cannot confirm systemic effects in humans.

Microbial Cross-Feeding and Metabolic Pathways

Greenvit employs membrane technology with water as a solvent to create Aronvit, a whole-spectrum extract designed to remain “as close to nature as possible.” The company’s standardization process begins with raw material testing for anthocyanin and polyphenol levels. Future studies in 2027 will expand donor participation to further explore aronia’s impact on gut health in collaboration with Polish medical universities.

Functional Approach to Ingredient Characterization

The study supports a functional approach to characterizing high-quality aronia ingredients, looking beyond chemical composition to microbial metabolism, SCFAs, and bioactive metabolites.

Greenvit emphasizes that extraction technology, matrix composition, fiber content, and microbial accessibility determine what happens when the ingredient reaches the gut.

Standardization should extend beyond anthocyanin or total polyphenol content to include functional metabolic outcomes.